1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Genomics Analysis & Statistics, June 2016 (p4)

Genomics Analysis & Statistics, June 2016 (p4)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

91-120 of about 1 200 reports

Purchase Reports From Reputable Market Research Publishers

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • June 2016
  • by Global Markets Direct

BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2016’, provides an overview of the BioMarin ...

  • Industries : Pharmaceutical, Research and Development
  • Countries : United States
Viral RNA Polymerase Inhibitors -Pipeline Insights, 2016

Viral RNA Polymerase Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Viral RNA Polymerase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Viral RNA Polymerase ...

  • Industries : Genomics
Viral DNA Polymerase Inhibitors -Pipeline Insights, 2016

Viral DNA Polymerase Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Viral DNA Polymerase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Viral DNA Polymerase ...

  • Industries : Genomics
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s -Pipeline Insights, 2016

Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Therapy
DNA Polymerase Beta Inhibitors -Pipeline Insights, 2016

DNA Polymerase Beta Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “DNA Polymerase Beta Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the DNA Polymerase ...

  • Industries : Genomics
RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors -Pipeline Insights, 2016

RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Genomics
DNA Polymerase Alpha Inhibitors -Pipeline Insights, 2016

DNA Polymerase Alpha Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “DNA Polymerase Alpha Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the DNA Polymerase ...

  • Industries : Genomics
DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2016

DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “DNA-Dependent RNA Polymerase Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the DNA-Dependent ...

  • Industries : Genomics
VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2016

VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development ...

  • Industries : Genomics
Automated Analyzers Market Outlook - Market Size, Segmentation, Market share & Competitive Landscape (2016-2021)

Automated Analyzers Market Outlook - Market Size, Segmentation, Market share & Competitive Landscape (2016-2021)

  • $ 800
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global automated analyzers market is projected to grow at a CAGR of XX.XX% and reach $XX.XX billion by 2021. Apart from reducing mundane tasks, the market for laboratory automation is also driven by ...

  • Industries : Genomics
XEPTAGEN SpA - Product Pipeline Analysis, 2016 Update

XEPTAGEN SpA - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary Xeptagen SpA (Xeptagen) is a medical device company that discovers molecular markers. The company produces diagnostic kits for the monitoring, detection, and screening of cancerous cells. It develops ...

  • Industries : Cancer
Chronix Biomedical, Inc. - Product Pipeline Analysis, 2016 Update

Chronix Biomedical, Inc. - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary Chronix Biomedical, Inc. (Chronix Biomedical) is a molecular diagnostic company that develops blood tests for monitoring minimal residual disease in cancer patients. The company offers tests, which ...

  • Industries : Cancer, Pathology, Mental Health
  • Countries : United States
VolitionRX Ltd. (VNRX) - Product Pipeline Analysis, 2016 Update

VolitionRX Ltd. (VNRX) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary VolitionRX Ltd. (VolitionRX) is a life science company that develops diagnostic solutions. The company develops blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. ...

  • Industries : Cancer, In Vitro Diagnostics, Pathology
  • Countries : Denmark, Europe, United States
Exosome Diagnostics, Inc. - Product Pipeline Analysis, 2016 Update

Exosome Diagnostics, Inc. - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • July 2016
  • by Global Data

Summary Exosome Diagnostics, Inc. (Exosome Diagnostics) is a medical device company that offers diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic ...

  • Industries : Diagnostics
  • Countries : United States
Sequenom, Inc. (SQNM) - Product Pipeline Analysis, 2016 Update

Sequenom, Inc. (SQNM) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary Sequenom, Inc. (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited ...

  • Industries : General Medicine and Specialty Medicine, Genomics
  • Countries : United States
MEDITE Cancer Diagnostics, Inc. (MDIT) - Product Pipeline Analysis, 2016 Update

MEDITE Cancer Diagnostics, Inc. (MDIT) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Industry report
  • June 2016
  • by Global Data

Summary MEDITE Cancer Diagnostics, Inc. (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, ...

  • Industries : Cancer, Diagnostics
  • Countries : United States, China
DiaGenic ASA (NEL) - Product Pipeline Analysis, 2016 Update

DiaGenic ASA (NEL) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Industry report
  • June 2016
  • by Global Data

Summary DiaGenic ASA (DiaGenic) is a medical company that creates value for patients, partners and investors by developing innovative and patient friendly in vitro diagnostic products for early detection ...

  • Industries : Genomics
  • Countries : Norway
GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis, 2016 Update

GenMark Diagnostics, Inc. (GNMK) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary GenMark Diagnostics, Inc. (GenMark) is a medical device company that offers clinical testing solutions. The company’s products include XT-8 systems and assays. It offers pipeline products such ...

  • Industries : Diagnostics, In Vitro Diagnostics, Pathology
  • Countries : United States
Exiqon AS (EXQ) - Product Pipeline Analysis, 2016 Update

Exiqon AS (EXQ) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary Exiqon A/S (Exiqon) is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company offers RNA, microRNA and LNA oligos products. Its RNA products ...

  • Industries : Cancer
BG Medicine, Inc. (BGMD) - Product Pipeline Analysis, 2016 Update

BG Medicine, Inc. (BGMD) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by Global Data

Summary BG Medicine, Inc. (BGM) formerly Beyond Genomics, Inc. is a medical device company that discovers, develops and delivers diagnostic solutions. The company offers diagnostics to aid in the clinical ...

  • Industries : Therapy, Chronic Disease
  • Countries : United States
Cancer Biomarkers Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Cancer Biomarkers Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The global cancer biomarkers market was valued at USD 13.16 billion in 2011 and is expected to reach USD 30.2 billion by 2019, growing at a CAGR of 14.60% during the forecast period 2011 to 2019. Biomarkers ...

  • Industries : Genomics
Regenerative Medicines Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Regenerative Medicines Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global Regenerative Medicines Market was valued at USD 16.4 billion in 2014 and is forecasted to reach USD 67.6 billion by 2020, growing at a CAGR of 18.9% during the forecast period from 2014 to 2019. ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : World
Molecular diagnostics market Outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

Molecular diagnostics market Outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global market for Molecular Diagnostics is poised to reach USD XX billion by 2021, growing at a CAGR of approximately XX% during the forecast period. Diagnosis based on Molecular or Nucleic acids fo ...

  • Industries : Genomics
  • Countries : World
Metabolomics  -  Market size, segmentation, market share and competitive landscape (2016-2021)

Metabolomics - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global Metabolomics Market is expected to reach $2.8 billion by the end of 2020 growing at a CAGR of around 26% from 2014 to 2020. Metabolomics is the identification and quantification of the complete ...

  • Industries : Genomics
  • Countries : World
Proteomics - Patent Overview in the years 2011 - 2016

Proteomics - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Proteomics is the study of protein structure and function. And at the cellular level, proteomics is, which proteins are expressed, when and where they are expressed, what their structure in both active ...

  • Industries : Genomics
Cytogenetics - Patent Overview in the years 2011 - 2016

Cytogenetics - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Cytogenetics is an exciting field of genetics, which deals with the study of chromosomes. It analyses the number, structure and composition of human and animal chromosomes. Chromosomal changes or modifications ...

  • Industries : Genomics
RNA Sequencing - Patent Overview in the years 2011 - 2016

RNA Sequencing - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

RNA sequencing (RNA-Seq) is an evolving, highly sensitive and accurate tool that uses deep-sequencing technologies (next-generation sequencing) for transcriptome profiling. It is more sensitive, more robust ...

  • Industries : Genomics
Toxicogenomics - Patent Overview in the years 2011 - 2016

Toxicogenomics - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Toxicogenomics is the newest breakthrough for risk analysis tool. It is defined as the application of knowledge of genes associated with disease states to the study of toxicology of chemical and physical ...

  • Industries : Genomics
  • Countries : World
Chip Sequencing - Patent Overview in the years 2011 - 2016

Chip Sequencing - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Chip-sequencing is a method that is used to analyze protein interaction with DNA. It combines the technique of chromatin immunoprecipitation with massively parallel DNA sequencing to identify the binding ...

  • Industries : Genomics
  • Countries : United States
Methyl Sequencing - Patent Overview in the years 2011 - 2016

Methyl Sequencing - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Methyl sequencing is primarily done to understand the methylation pattern in a DNA. DNA methylation is said to be the first discovered epigenetic mark. DNA methylation is the most commonly studied in epigenetics. ...

  • Industries : Genomics
About 4 800 reports

Download Unlimited Documents from Trusted Public Sources

Genomics Industry in the US

  • August 2016
    11 pages
  • Genomics  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.